Article thumbnail
Location of Repository

Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas

By Abelardo Meneses-García, Alejandro Mohar Betancourt, Jorge Herrera Abarca, Adriana Becerril Montes, Lourdes Suarez Roa and Luz Ruíz-Godoy
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (1991). A polyadenylate binding protein localized to the granules of cytolytic induces DNA fragmentation in target cells. Cell
  2. (1994). An immunohistochemical study of extracellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic potential. Virchows Arch
  3. (2000). Aspirin inhibitors tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression. Cancer Res
  4. (2000). ES: Aggressive NK cell lymphoma insights in to the spectrum of NK cell derived malignancies. Histopathology
  5. (1998). ES: Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/ natural killer cell lymphomas from Mexico. Mod Pathol
  6. (1994). ES: High grade AIL and Epstein-Barr virus infection in 22 cases from Mexico. Mod Pathol
  7. (1993). ES: Nasal lymphomas in Peru, high incidence of T-cell immunophenotype and Epstein-Barr virus infection.
  8. (2005). ES: The pathology of NK-cell lymphomas and leukemias. Adv Anat Pathol
  9. (1995). et al.: Clinicopathologic study of CD 56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract.
  10. (2002). Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and metalloproteinase 9 in carcinoma of the head and neck. Correlation with p53 status, inductible nitric oxide synthase activity, and angiogenesis. Cancer
  11. (1988). F: Lethal midline granuloma (polymorphic reticulosis) and lymphomatoid granulomatosis: evidence for monoclonal T-cell lymphoproliferative disorder. Cancer
  12. (2001). F: p53 mutations in nasal natural killer/cell lymphoma from Mexico. Association with large cell morphology and advanced disease.
  13. (1995). Guillem JG: Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph nodes and distant metastasis. Clin Cancer Res
  14. (1996). HA: Primary lymphoma of the nose including a relationship of lethal midline granuloma.
  15. (1996). Ho FCS: Report of the workshop on nasal an related extranodal angiocentric T/natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology.
  16. (1989). I: Nation-wide study of lethal midline granuloma in japan: frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions.
  17. (1985). Ishi Y: Tcell lymphoma: characterization by monoclonal antibodies. Ann Otol Rhinol Laryngol
  18. (1999). Janowska-Wieczorek A: Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas. Blood
  19. (1984). Khoo RKK: Features of malignant lymphomas in 294 Hong Kong Chinese patients, retrospective study covering an eight year period.
  20. (2004). López-Otín C: Matriz metalloproteinases in cancer: from new functions to improved inhibition strategies.
  21. (1996). LS: A n a l y s i s o f E p s t e i n - B a r r g e ne polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood
  22. (1998). Pagano JS: The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein1. Proc Natl Acad Sci USA
  23. (1984). Pathologic and clinical spectrum of post-thymic Tcell malignancies. Cancer Investigation
  24. (1999). Shirasuna K: Expression of MMPs, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck
  25. (2000). Sinonasal T/NK cell lymphomas in the United States. Am J Surg Pathol
  26. Stetler-Stevenson WG: Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells.
  27. (1995). Trapane JAA: Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today
  28. (2002). Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nature Reviews/Cancer
  29. (1997). WH: Non-nasal lymphomas expressing the natural killer cell marker CD 56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood
  30. (1998). Y: bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T-lymphoma/endothelial cell contact.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.